AIDS‐related lymphoid neoplasia. The memorial hospital experience

Cancer

Volumn 61, Issue 11, 1988, Pages 2325-2337

  Lowenthal, Dennis A ^a   Straus, David J ^a   Campbell, Susanne Wise ^a   Gold, Jonathan W M ^a   Clarkson, Bayard D ^a   Koziner, Benjamin ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CHLORMETHINE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; METHOTREXATE; MITOGUAZONE; PREDNISONE; PROCARBAZINE; VINCRISTINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BRAIN LYMPHOMA; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; HODGKIN DISEASE; HUMAN; LYMPHOMA, NON-HODGKIN; PROGNOSIS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023929189     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19880601)61:11<2325::AID-CNCR2820611130>3.0.CO;2-0     Document Type: Article

References (85)

1. Kaposi's sarcoma and pneumocystis pneumonia among homosexual men: New York City and California
2. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: Evidence of a new acquired cellular immunodeficiency
3. An outbreak of community acquired pneumocystis carinii pneumonia: Initial manifestation of cellular immune dysfunction
4. Severe acquired immunodeficiency in male homosexuals manifested by chronic perianal ulcerative Herpes simplex lesions
5. Acquired immunodeficiency syndrome (AIDS) associated with transfusions
6. Acquired immunodeficiency syndrome with pneumocystis carinii pneumonia and mycobacterium avium‐intracellulare infection in a previously healthy patient with classic hemophilia: Clinical, immunologic and virologic findings
7. Characteristics of the acquired immunodeficiency syndrome (AIDS) in Haiti
8. Immunodeficiency in female sexual partners of men with acquired immunodeficiency syndrome
9. Acquired immunodeficiency with reversed T4/T8 ratio in infants born to promiscuous and drug‐addicted mothers
10. Immunologic abnormalities in the acquired immunodeficiency syndrome
11. A human T‐lymphotropic retrovirus (HTLV‐III) as the cause of the acquired immunodeficiency syndrome
12. Lymphadenopathy‐associated virus from molecular biology to pathogenicity
13. Antibodies reactive with human T‐lymphotrophic retroviruses (HTLV‐III) in the serum of patients with AIDS
14. Depressed immunity and the development of cancer
15. Genetically determined immunodeficiency disease (GDID) and malignancy: Report from the immunodeficiency cancer registry
16. Malignancies associated with immunosuppressive or cytotoxic therapy
17. Leukemias and lymphomas associated with the use of cytotoxic and immunosuppressive drugs
18. Revision of the case definition of acquired immunodeficiency syndrome for national reporting: United States
19. The non‐Hodgkin's lymphoma pathologic classification project. National Cancer Institute sponsored study of classifications of non‐Hodgkin's Lymphomas
20. Report of the nomenclature committee
21. Report of the committee on Hodgkin's disease staging
22. Acquired immunodeficiency syndrome in the development of lymphoma
23. Non‐Hodgkin's lymphoma in 90 homosexual men: Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome
24. Neurological complications of acquired immune deficiency syndrome: Analysis of 50 patients
25. Plasmacytoma and the acquired immunodeficiency syndrome
26. Steroid related development of Kaposi's sarcoma in a homosexual man with Burkitt's lymphoma
27. Specific translocations characterize Burkitt's‐like lymphoma of homosexual men with the acquired immunodeficiency syndrome
28. Analysis of T‐cell subsets in different clinical subgroups of patients with the acquired immune deficiency syndrome: Comparison with the “classic” form of Kaposi's sarcoma
29. Nonparametric estimation from incomplete observations
30. Combination chemotherapy of diffuse histiocytic lymphoma with cyclophosphamide, adriamycin, vincristine, and prednisone (CHOP)
31. The NHL‐7: Alternating non‐cross resistant, combination chemotherapy (CT) containing methyl‐GAG (MG) for diffuse (D) non‐Hodgkin's lymphoma (NHL) (Abstr)
32. Lymphoblastic lymphoma in adults
33. Moderate dose methotrexate (M) combined with bleomycin (B), adriamycin (A), cyclophosphamide (C), oncovin (O), and dexamethasone (D), m‐BACOD in advanced diffuse histiocytic lymphoma (DHL) (Abstr)
34. Diffuse aggressive lymphomas: Increased survival after alternating flexible sequence of ProMACE and MOPP chemotherapy
35. MACOP‐B chemotherapy for the treatment of diffuse large‐cell lymphoma
36. Malignant neoplasms in AIDS
37. Lymphomas in men at high risk for acquired immune deficiency syndrome (AIDS): A study of 21 cases
38. Development of B‐cell lymphoma in homosexual men: Clinical and immunologic findings
39. Primary central nervous system lymphoma in homosexual men: Clinical immunologic and pathologic features
40. Aggressive non‐Hodgkin's lymphomas in immunocompromised homosexual males
41. Rectal lymphoma in homosexual men
42. Multiple myeloma in a homosexual man with chronic lymphadenopathy
43. Lymphoblastic neoplasia in a homosexual patient with Kaposi's sarcoma
44. Burkitt cell acute lymphoblastic leukemia with partial expression of T‐cell markers and subclonal chromosome abnormalities in a man with acquired immunodeficiency syndrome
45. Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M‐BACOD)
46. Cyclophosphamide, vincristine, methotrexate and leucovorin rescue, and cytarabine (COMLA) combination sequential chemotherapy for advanced diffuse histiocytic lymphoma
47. Diffuse aggressive lymphomas: Increased survival after flexible sequences of ProMACE and MOPP chemotherapy
48. Retrovirus and the malignant lymphoma in homosexual men
49. Central nervous system complications in patients with diffuse histiocytic and undifferentiated lymphoma: Leukemia revisited
50. Central nervous system relapse in malignant lymphoma: Risk factors and implications for prophylaxis
51. CNS involvement in the non‐Hodgkin's lymphomas
52. Primary malignant lymphomas of the central nervous system
53. Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: Clinical and neuropathological findings in 27 patients
54. Primary lymphoma of the CNS (Letter)
55. The AIDS dementia complex: II. Neuropathology
56. Primary non‐Hodgkin's lymphoma of the brain: A review
57. Defective regulation of Epstein‐Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) on AIDS‐related disorders
58. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein‐Barr virus
59. Infectious mononucleosis in an adult progressing to fatal immunoblastic lymphoma
60. Epstein‐Barr virus immunity and tissue distribution in a fatal case of infectious mononucleosis
61. Central nervous system lymphoma related to Epstein‐Barr virus
62. Small non‐cleaved B‐cell Burkitt‐like lymphoma with chromosome t(8;14) translocation and Epstein‐Barr virus nuclear‐associated antigen in a homosexual man with acquired immune deficiency syndrome
63. Malignant lymphoma presenting as Kaposi's sarcoma in a homosexual man with the acquired immunodeficiency syndrome
64. Pathogenesis of B‐cell lymphoma in a patient with AIDS
65. An EBV genome carrying pre‐B cell leukemia in a homosexual man with characteristic karyotype and impaired EBV‐specific immunity
66. Surface markers on human B‐ and T‐lymphocytes: II. Presence of Epstein‐Barr virus receptors on B‐lymphocytes
67. Polyclonal immunoglobulin production after Epstein‐Barr virus of human lymphocytes in vitro
68. Diffuse polyclonal B‐cell lymphoma during primary infection with Epstein‐Barr virus
69. T‐cell mediated immuno‐regulation of Epstein‐Barr virus (EBV) induced B‐lymphocyte activation in EBV seropositive and EBV seronegative individuals
70. Epstein‐Barr virus infection and immunoregulation in man
71. Evolution of tumors and the impact of molecular oncology
72. Burkitt's lymphoma in AIDS: Cytogenetic study
73. Human c‐myc oncogene is located on the region of chromosome 8 that is translocated in Burkitt's lymphoma cells
74. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders
75. Association of Hodgkin's and non‐Hodgkin's lymphomas with the acquired immunodeficiency syndrome (AIDS)
76. Hodgkin's disease and the acquired immunodeficiency syndrome
77. Hodgkin's disease in homosexual men with generalized lymphadenopathy
78. Acquired immune deficiency syndrome in homosexual men with Hodgkin's disease: Three case reports
79. Atypical Hodgkin's disease and the acquired immunodeficiency syndrome (Letter)
80. Simultaneous occurrence of Hodgkin's disease and Kaposi's sarcoma in a patient with acquired immune deficiency syndrome
81. Hodgkin's disease in AIDS complex patients: Report of four cases and tissue immunologic marker studies
82. Lymphoreticular disorders in primary immunodeficiencies: New findings based on an up‐to‐date histologic classification of 35 cases
83. Persistent immunologic abnormalities in long‐term survivors of advanced Hodgkin's disease